$2.39T
Total marketcap
$71.89B
Total volume
BTC 50.56%     ETH 14.99%
Dominance

Bliss GVS Pharma Limited BLISSGVS.NS Stock

112.5 INR {{ price }} -2.216430% {{change_pct}}%
COUNTRY
India
Exchange
NSE
Market Cap
11.78B INR
LOW - HIGH [24H]
111.3 - 116.1 INR
VOLUME [24H]
406.27K INR
{{ volume }}
P/E Ratio
13.55
Earnings per share
8.3 INR

Bliss GVS Pharma Limited Price Chart

Bliss GVS Pharma Limited BLISSGVS.NS Financial and Trading Overview

Bliss GVS Pharma Limited stock price 112.5 INR
Previous Close 81.1 INR
Open 82.35 INR
Bid 82.2 INR x 0
Ask 82.3 INR x 0
Day's Range 81.65 - 83.15 INR
52 Week Range 69.2 - 91.3 INR
Volume 212.5K INR
Avg. Volume 168.03K INR
Market Cap 8.55B INR
Beta (5Y Monthly) 0.488698
PE Ratio (TTM) 12.630769
EPS (TTM) 8.3 INR
Forward Dividend & Yield 0.5 (0.63%)
Ex-Dividend Date July 12, 2023
1y Target Est N/A

BLISSGVS.NS Valuation Measures

Enterprise Value 8.13B INR
Trailing P/E 12.630769
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.1382006
Price/Book (mrq) 0.91349095
Enterprise Value/Revenue 1.081
Enterprise Value/EBITDA 6.928

Trading Information

Bliss GVS Pharma Limited Stock Price History

Beta (5Y Monthly) 0.488698
52-Week Change 9.66%
S&P500 52-Week Change 20.43%
52 Week High 91.3 INR
52 Week Low 69.2 INR
50-Day Moving Average 75.32 INR
200-Day Moving Average 75.24 INR

BLISSGVS.NS Share Statistics

Avg. Volume (3 month) 168.03K INR
Avg. Daily Volume (10-Days) 205.28K INR
Shares Outstanding 104.2M
Float 34.75M
Short Ratio N/A
% Held by Insiders 65.41%
% Held by Institutions 9.20%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.5
Trailing Annual Dividend Yield 0.61%
5 Year Average Dividend Yield 62.00%
Payout Ratio 0.0744
Last Split Factor 8:5

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 9.42%
Operating Margin (ttm) 13.12%
Gross Margin 46.60%
EBITDA Margin 15.60%

Management Effectiveness

Return on Assets (ttm) 5.44%
Return on Equity (ttm) 8.70%

Income Statement

Revenue (ttm) 7.52B INR
Revenue Per Share (ttm) 72.45 INR
Quarterly Revenue Growth (yoy) 10.59%
Gross Profit (ttm) N/A
EBITDA 1.17B INR
Net Income Avi to Common (ttm) 708.59M INR
Diluted EPS (ttm) 6.5
Quarterly Earnings Growth (yoy) -83.00000000000000000000000000000000%

Balance Sheet

Total Cash (mrq) 1.08B INR
Total Cash Per Share (mrq) 10.98 INR
Total Debt (mrq) 1.02B INR
Total Debt/Equity (mrq) 11.11 INR
Current Ratio (mrq) 3.608
Book Value Per Share (mrq) 89.875

Cash Flow Statement

Operating Cash Flow (ttm) 343.14M INR
Levered Free Cash Flow (ttm) 199.88M INR

Profile of Bliss GVS Pharma Limited

Country India
State N/A
City Mumbai
Address 102, Hyde Park
ZIP 400072
Phone 91 22 4216 0000
Website https://www.blissgvs.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Q&A For Bliss GVS Pharma Limited Stock

What is a current BLISSGVS.NS stock price?

Bliss GVS Pharma Limited BLISSGVS.NS stock price today per share is 112.5 INR.

How to purchase Bliss GVS Pharma Limited stock?

You can buy BLISSGVS.NS shares on the NSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bliss GVS Pharma Limited?

The stock symbol or ticker of Bliss GVS Pharma Limited is BLISSGVS.NS.

Which industry does the Bliss GVS Pharma Limited company belong to?

The Bliss GVS Pharma Limited industry is Drug Manufacturers-Specialty & Generic.

How many shares does Bliss GVS Pharma Limited have in circulation?

The max supply of Bliss GVS Pharma Limited shares is 104.69M.

What is Bliss GVS Pharma Limited Price to Earnings Ratio (PE Ratio)?

Bliss GVS Pharma Limited PE Ratio is 13.55421600 now.

What was Bliss GVS Pharma Limited earnings per share over the trailing 12 months (TTM)?

Bliss GVS Pharma Limited EPS is 8.3 INR over the trailing 12 months.

Which sector does the Bliss GVS Pharma Limited company belong to?

The Bliss GVS Pharma Limited sector is Healthcare.